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Single-lung transplantation has been abandoned for the treatment of 
pulmonary hypertension by many centers because of overperfusion of the 
graft following implantation. Euro-Collins solution is currently used for 
lung preservation despite the vasoconstrictive effect of this intracellular- 
type solution. We hypothesized that high-flow reperfusion, alone or in 
combination with Euro-Collins-induced vasoconstriction, may cause lung 
dysfunction. Twenty-eight New Zealand White rabbit lungs were harvested 
and studied in an isolated, blood-perfused model of lung function after 4 
hours of cold ischemia. Control lungs were preserved with 50 ml/kg cold 
saline solution flush and reperfused at either normal flow (60 ml/min) or 
high flow (120 ml/min). Experimental lungs were preserved with 50 ml/kg 
cold Euro-Collins solution and reperfused at normal or high flow rates. The 
arteriovenous oxygen gradient at the end of the 30-minute reperfusion 
period was significantly lower in the high-flow versus the low-flow experi- 
mental group (31.1 - 4.2 vs 130.6 +- 41.6 mm Hg, p < 0.05). The pulmonary 
vascular esistance was increased in the high-flow groups and the experi- 
mental groups, with a statistically significant difference between low-flow 
experimental nd control groups (64374.4 -+ 5722.6 vs 37041.5 --4-- 2110.9 
dynes • sec • cm -s, p < 0.001). The percentage decrease in dynamic airway 
compliance in the high-flow experimental group was markedly different 
from that in the high-flow control group (-51% - 13.3% vs -10.15% - 
3.4%, p < 0.05). Similarly, the wet/dry ratio of the lungs in the high.flow 
experimental group (13 .92  - 2.32) was significantly greater than that in the 
low-flow experimental group (6.27 - 0.19, p < 0.01) and than that in the 
high-flow control group (5.88 +_ 0.23, p < 0.001). These data demonstrate 
that high-flow reperfusion and preservation with Euro-Collins solution are 
deleterious to lung function, both individually and in combination, in an ex 
vivo rabbit lung model. Lung preservation with Euro-Collins solution may 
not be optimal when high-flow reperfusion is anticipated, as in the setting 
of unilateral lung transplantation for pulmonary hypertension. (J Thorac 
Cardiovasc Surg 1996;112:111-6) 
D espite the acceptable results now being achieved with clinical lung transplantation, early graft 
dysfunction is still an important cause of morbidity 
and mortality. 1 The mechanism responsible for this 
primary graft dysfunction is not always apparent, but 
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it is more common in single-lung transplantation for 
pulmonary hypertension. 2' 3 The diversion of the 
entire cardiac output to the newly implanted lung 
results in significant pulmonary hypertension and 
increased microvascular hydrostatic pressure, lead- 
ing to edema formation and hypoxemia. Although 
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this process is potentially reversible, the resultant 
pulmonary insufficiency occasionally proves fatal. 
Lung preservation with Euro-Collins solution 
(EC) remains the current clinical standard, even in 
the setting of unilateral lung transplantation for 
pulmonary hypertension. The high potassium con- 
tent in this intracellular-type solution is known to 
induce potent pulmonary vasoconstriction. 4 In an 
effort to promote an even distribution of cold EC 
flush throughout the graft, prostaglandin E 1 (PGE1) 
is routinely administered before flush. Although this 
strategy has shown improvements in EC lung pres- 
ervation, s unfavorable comparisons with other solu- 
tions suggests that EC may not be the ideal preser- 
vation solution for the lung. 6 Moreover, the 
potassium-induced increase in vascular tone seen 
with EC may not be completely eliminated by PGE 1 
administration at reperfusion. 7 
Most studies relating to lung preservation take 
place in experimental models with normal reperfu- 
sion flow rates. Approaching the problem of early 
graft failure from a different viewpoint, we hypoth- 
esized that lung function is impaired by high-flow 
reperfusion, as occurs with single-lung transplanta- 
tion in patients with pulmonary hypertension. Our 
second hypothesis was that the resultant injury is 
further aggravated by EC-induced vasoconstriction. 
These hypotheses were investigated by studying 
lungs after 4 hours of cold ischemia and pretreat- 
ment with PGE 1 with an isolated, blood-perfused 
rabbit lung model. 
Material and methods 
Lung-heart block harvesting. Twenty-eight New Zeal- 
and White rabbits (3.0 to 3.5 kg) were randomly assigned 
to four groups of seven animals each. Each rabbit was 
anesthetized with intramuscular ketamine (50 mg/kg) and 
xylazine (5 mg/kg). All animals received humane care in 
compliance with the "Principles of Laboratory Animal 
Care" formulated by the National Society for Medical 
Research and the "Guide for the Care and Use of 
Laboratory Animals" prepared by the Institute of Labo- 
ratory Animal Resources and published by the National 
Institutes of Health (NIH publication No. 85-23, revised 
1985). 
A tracheostomy was performed and followed by paral- 
ysis with metocurine (0.2 mg/kg). Mechanical ventilation 
was instituted (ventilator RSP1002; Kent Scientific Cor- 
poration, Litchfield, Conn.) with room air at a tidal 
volume of 12 ml/kg and a rate of 20 breaths/min. Median 
sternotomy and thymectomy were then performed. The 
superior and the inferior venae cavae were loosely encir- 
cled with ligatures and the pericardium was opened. Both 
the pulmonary artery (PA) and aorta were dissected free 
and similarly encircled. A purse-string suture was then 
placed in the free wall of the right ventricle, and the rabbit 
was heparinized (500 U/kg). After injection of 30 /xg 
PGE 1 into the PA, the venae cavae were ligated and the 
time of ischemia onset was charted. The PA was then 
cannulated through the right ventricular purse-string su- 
ture, and both the right ventricular and PA ligatures were 
tied around the cannula. After venting of the left ventricle 
and ligation of the aorta, 50 ml/kg preservation solution at 
4°C was infused into the PA from a height of 30 cm. 
Topical cooling was achieved with cold saline solution 
slush. During PA flush, the left atrium was cannulated 
through the left ventricle and a second purse-string suture 
was tied around the cannula. After the PA flush, the 
inflow and outflow cannulas were clamped. Care was 
taken to leave the pleurae intact until completion of the 
flush, to avoid parenchymal injury. The tracheostomy tube 
was then clamped at end-inspiration, and the lung-heart 
block was excised and immersed in cold normal saline 
solution and then stored at4 ° C. 
Assessment of lung function. After 4 hours of storage, 
the lung-heart blocks were suspended by force trans- 
ducer in a warmed, humidified tissue chamber (Fig. 1). 
Ventilation was reestablished with 95% oxygen and 5% 
carbon dioxide at a tidal volume of 12 ml/kg and a rate 
of 20 breaths/rain. The lungs were reperfused with 
homologous flesh whole venous blood from a main 
reservoir. A second venous blood reservoir was used to 
determine single-pass oxygenation. Blood was har- 
vested from a single rabbit for each experiment. The 
inflow and outflow cannulas were then connected to the 
blood-filled perfusion circuit, with care taken to avoid 
the introduction of air bubbles. The circuit (Kent 
Scientific) was designed to recirculate 200 ml of 
warmed blood through a 270 txm blood filter (2C7600; 
I.V. Systems Division, Baxter Healthcare Corp., Deer- 
field, Ill.) with a roller pump (7521-40; Cole-Parmer 
Instrument Company, Niles, Ill.) at a rate of 60 or 120 
ml/min, in accordance with the experimental protocol. 
A 270 tzm blood filter was chosen to avoid affecting 
leucocyte or platelet counts. Continuous recordings of 
PA pressure, pulmonary venous pressure, lung weight, 
airway flow, and airway pressure were carried out with 
a dynamic data-acquisition program (Workbench PC; 
Strawberry Tree, Inc., Sunnydale, Calif.) on a personal 
computer (470A; Compaq Prolinea, Houston, Texas). 
This program allowed immediate calculation of pulmo- 
nary vascular esistance (PVR), tidal volume, and dy- 
namic airway compliance. The pulmonary venous pres- 
sure was maintained within the physiologic range (4 to 
8 mm Hg) by setting the appropriate height of a small 
outflow reservoir in the circuit. Pulmonary venous 
blood samples were collected for blood gas analysis 
(Corning 178 pH/Blood Gas Analyser; Corning Inc., 
Coming, N.Y.) at 10, 20, and 30 minutes after the start 
of reperfusion; at each sampling time, inflow from the 
main reservoir was interrupted and the circuit was filled 
with venous blood from the second inflow reservoir. A
30 ml sample of venous blood was passed through t e 
pulmonary vasculature at each interval to ensure accu- 
rate measurement of oxygen content. Oxygen contact 
with exposed blood surfaces inside the reservoir con- 
tainers was minimized by the continuous passive infu- 
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Fig. 1. Schematic of isolated ventilated and blood perfused rabbit lung model. P, Pressure transducer; N2, 
nitrogen gas. 
sion of 100% nitrogen. After 30 minutes of reperfusion, 
lung samples were taken for histologic analysis and 
calculation of wet/dry weight ratio after passive desic- 
cation. 
Experimental protocol. Lungs were flushed with nor- 
mal saline solution or EC and reperfused at a normal (60 
ml/min, $60 and EC60) or high flow rate (120 ml/min $120 
and EC120; Table I). Saline solution was chosen to rinse 
the lungs in the control groups because of its inert 
endothelial effects. Data were obtained very 15 seconds 
and analyzed at the end of the 30-minute reperfusion 
period. All values are expressed as mean ± standard error 
of the mean. 
Statistical analysis was performed by analysis of 
variance and Kruskal-Wallis nonparametric analysis of 
variance was used to compare different solutions at the 
same flow rate and the influence of flow rate on lungs 
preserved with the same solution. Differences were 
considered statistically significant if thep value was less 
than 0.05. 
Results 
There were no significant differences among 
groups in donor weight, total ischemic time, or 
hematocrit. Mean hematocrit for all groups com- 
bined was 29.53% ± 0.33%. The arteriovenons 
oxygen gradient at the end of the 30-minute reper- 
fusion period was significantly lower in both high- 
flow groups compared with the normal flow groups 
Table I. Experimental protocoI and group 
designations 
Group Preservation solution Reperfusion flow 
(n = 7) (50 ml/kg) (ml/min) 
$60 Saline 60 
$120 Saline 120 
EC60 EC 60 
EC120 EC 120 
($120 75.8 + 13.0 vs $60 284.6 _+ 45.6 mm Hg, p < 
0.01; EC120 31.1 _+ 4.2 vs EC60 130.6 _+ 41.6 mm 
Hg, p < 0.05). The arteriovenous oxygen gradient 
was also lower in the EC groups than in the saline 
solution groups at the same flow rates, but this 
difference was not statistically significant (Fig. 2). 
The hemodynamic data recorded during reperfu- 
sion revealed pulmonary hypertension and in- 
creased PVR in the high-flow groups (Table II). 
These hemodynamic derangements were especially 
marked in the EC120 group. Fig. 3 demonstrates a 
continuous tracing of PVR throughout the 30- 
minute reperfusion period for groups $60 and 
EC60. Similarly, the percentage decrease in dynamic 
airway compliance was significant in the EC groups. 
The lung water content at 30 minutes of reperfusion, 
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Fig. 2. Pulmonary arteriovenous (P A-V) oxygen gradients at 10, 20, and 30 minutes of reperfusion. 
Oxygenation declines in high-flow groups and EC groups during reperfusion. All values expressed as 
mean + standard error of the mean (at the end of reperfusion period, p < 0.01 $60 vs $120;p < 0.05 EC60 
vs EC120). 
Table II. Results after 30 minutes of reperfusion 
PAP PVR CPL Wet~dry 
Group (mm Hg) (dynes • sec • cm -s) change (%) rate 
$60 34.4 + 1.8" 37041.5 + 2110.9" -4.22 + 1.9 5.78 + 0.1 
$120 110.5 ± 11.6 68197.5 _+ 7627.1 -10.15 ___ 3.4 5.88 ± 0.23? 
EC60 52.1 ± 4.95 64374.6 _+ 5722.65 -23.9 ± 13 6.27 ± 0.19§ 
EC120 127.1 _+ 19.91] 79848.1 ± 8412.6 -51 ± 13.3¶ 13.92 ± 2.23 
All data are mean -+ standard error of the mean. PAP, PA pressure; CPL, dynamic airway compliance. 
*p < 0.005 ($60 vs S120). 
tp < 0.001 (S120 vs EC120). 
~:p < 0.001 (EC60 vs $60). 
§p < 0.01 (EC60 vs EC120). 
PIP < 0.005 (EC120 vs EC60). 
¶p < 0.05 (EC120 vs $120). 
as expressed by wet/dry ratio, was significantly 
greater in the EC120 group (Table II). 
Discussion 
EC, an intracellular-type preservation solution, 
was first introduced for renal preservation. Its ap- 
plication to pulmonary transplantation was based on 
theoretic advantages, uch as prevention of cell 
swelling, conservation of energy stores, and minimi- 
zation of intracellular potassium loss. s The high 
potassium concentration of EC depolarizes smooth- 
muscle cell membranes, however, causing increased 
vascular tone and ultimately vascular obstruction. 9 
The severe vasoconstriction during pulmonary flush 
prevents uniform distribution of the solution, result- 
ing in uneven cooling and inadequate preserva- 
tion. 1° The administration of PGE 1 before PA flush 
is a routine clinical practice designed to overcome 
the EC-mediated vaconstriction. This concept was 
based on experimental studies showing improved 
pulmonary preservation with PGE~ pretreatment. 5 
Lung preservation with EC or other intracellular- 
type solutions has, however, led to unpredictable 
results in lung transplantation. 11'12 Such varied 
results may be related to ineffective counteraction 
of EC-induced vasoconstriction. To evaluate the 
independent effect of a persistent increase in PVR 
during reperfusion, we studied lung function after 
a short cold storage period, thereby minimizing 
the confounding effects of ischemia-reperfusion 
injury. 
Primary graft failure is of special concern in the 
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Fig. 3. PVR during 30 minutes in groups reperfused at normal flow. V ues are expressed as mean -+ 
standard error f the mean (at the end of reperfusion period, p < 0.001 $6  vs ED60). 
setting of pulmonary hypertension. Because of do- 
nor shortage and high mortality rates for patients 
with pulmonary hypertension awaiting transplanta- 
tion, unilateral lung transplantation has been advo- 
cated. 13 In this study, impairment of lung function 
by high-flow reperfusion was well demonstrated. 
Lungs preserved with saline solution displayed a 
decrease in oxygenation, an increase in PVR, and 
pulmonary hypertension when reperfused at a high 
flow rate. Despite these detrimental changes, pul- 
monary edema formation was minimal and dynamic 
airway compliance was normal. The lungs preserved 
with EC, however, had not only impaired oxygen- 
ation, increased PVR, and pulmonary hypertension, 
but also severe pulmonary edema formation. This 
last is demonstrated bya marked decrease in airway 
compliance and an increased wet/dry ratio. These 
impairments are evidence of further compromise of 
lung function, probably as a result of potassium- 
induced pulmonary vasoconstriction not effectively 
counteracted by administration of PGE 1. 
The PVR data shown in Fig. 3 demonstrate a 
severe initial increase in the PVR of the group 
preserved with EC and reperfused at a normal flow 
rate. PVR stabilized 5 to 10 minutes after a signifi- 
cant decrease, perhaps as the high potassium con- 
centration was washed out during reperfusion. Dur- 
ing this period of transient high PVR, however, 
substantial lung injury can occur. A possible limita- 
tion of this rabbit model may be the sensitivity of 
rodent pulmonary vasculature to high concentra- 
tions of potassium, although similar vasoconstrictive 
effects are seen in human vasculature. Low reperfu- 
sion pressure has been shown to attenuate both 
coronary endothelial and left ventricular dysfunc- 
tion.t4, 15 It is conceivable that low-flow reperfusion 
may similarly reduce pulmonary endothelial dys- 
function, pulmonary hypertension, and subsequent 
edema formation. To more effectively mitigate isch- 
emia-reperfusion injury to the lung, which is char- 
acterized by an elevation in PVR and an increase in 
microvascular permeability, t6 efforts should be di- 
rected at preserving not only parenchymal viability 
but also endothelial function. In addition to the 
vasoconstrictive properties of EC, other mecha- 
nisms resulting in cellular injury may play a role. 
Solutions with high potassium concentrations have 
not been unequivocally proved to ameliorate lung 
preservation; on the contrary, our study provides 
clear evidence that such solutions can actually be 
detrimental to pulmonary function. 
In conclusion, high-flow reperfusion results in 
substantial impairment of lung function, which is 
further potentiated by the high potassium concen- 
tration of EC. Just as cardioprotective strategies 
have evolved and ifferent methods of myocardial 
protection have been adapted to various clinical 
situations, alternative solutions and lung preserva- 
tion methods should be adapted to the clinical 
condition in lung transplantation. A definite need 
for further studies with other pulmonary preserva- 
tion solutions exists, especially in situations were 
lungs are either injured before procurement or are 
subjected to abnormal conditions during reperfu- 
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sion. Preservation of lung grafts with EC may not be 
optimal when high-flow reperfusion is anticipated, 
as in the setting of unilateral lung transplantation 
for pulmonary hypertension. 
We thank Mr. Anthony Herring for his invaluable 
technical assistance. 
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